PT  - JOURNAL ARTICLE
AU  - Sylvester, Bruce
ED  - Kapur, Akhil
TI  - PCI is a “Reasonable” Strategy for Diabetic Patients with Multivessel Disease: The CARDia Trial
DP  - 2008 Nov 01
TA  - MD Conference Express
PG  - 19--20
VI  - 8
IP  - 6
4099  - http://mdc.sagepub.com/content/8/6/19.short
4100  - http://mdc.sagepub.com/content/8/6/19.full
AB  - At 1 year following intervention, there apparently is no difference between coronary artery bypass grafting and percutaneous coronary intervention in treating diabetic patients with multivessel disease, as measured by the incidence of a composite of death, myocardial infarction, and stroke. These results are part of the Coronary Artery Revascularization in Diabetes [CARDia; ISRCTN19872154] trial.